TANATRIL

This brand name is authorized in Austria, Hong Kong SAR China, Japan, Poland, Singapore, Tunisia, Turkey, UK.

Active ingredients

The drug TANATRIL contains one active pharmaceutical ingredient (API):

1	Imidapril UNII 7NSF9GG1NU - IMIDAPRIL HYDROCHLORIDE
	The hypotensive effect of imidapril in hypertension appears to result primarily from the suppression of the plasma renin-angiotensin-aldosterone system.
	Read more about Imidapril

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TANATRIL Tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09AA16	Imidapril	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09A ACE inhibitors, plain → C09AA ACE inhibitors, plain
Discover more medicines within C09AA16

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
GB	Medicines & Healthcare Products Regulatory Agency	13984, 146233, 162626, 21798, 21861
HK	Department of Health Drug Office	51393, 51394
JP	医薬品医療機器総合機構	2144008F1021, 2144008F2028, 2144008F3024
PL	Rejestru Produktów Leczniczych	100124207, 100124220, 100124236
SG	Health Sciences Authority	10614P, 10615P
TN	Direction de la Pharmacie et du Médicament	6653463, 6653464
TR	İlaç ve Tıbbi Cihaz Kurumu	8699543010465, 8699543010472, 8699543010489, 8699543010496, 8699543010502, 8699543010519, 8699543010793, 8699543010809, 8699543010816